Literature DB >> 3884337

Basement membrane formation and lung cell differentiation in vitro.

B Zimmermann, H J Barrach, H J Merker, N Hinz.   

Abstract

In high density cultures of mouse fetal lung cells, so-called "mass cultures", development of organoid structures, formation of a basement membrane (BM), and differentiation of pneumocytes type II occur accompanied by synthesis and secretion of lamellar bodies. The relationship between the formation of a BM, on the one hand, and morphogenesis as well as differentiation of pneumocytes type II, on the other hand, has been investigated by use of antibodies against BM components in the lung mass culture. It is shown here that anti-laminin antibodies prevented BM formation, but morphogenesis and pneumocyte differentiation occurred as in untreated cultures. Short-term treatment with the antibody revealed that the BM is formed only during the first 2 to 3 days in vitro. Already formed BM could not be removed by anti-laminin. Anti-collagen type IV antibodies showed no effect in the lung mass culture except for a stronger staining of the BM. Anti-BM-1 antibodies caused no changes in morphogenesis, cell differentiation and BM formation either, but the mesenchymal intercellular space exhibited a dark staining, which is probably due to antigen-antibody complexes. The results obtained with anti-laminin antibodies indicate that a BM is not necessary for lung cell differentiation in vitro.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3884337

Source DB:  PubMed          Journal:  Eur J Cell Biol        ISSN: 0171-9335            Impact factor:   4.492


  2 in total

1.  Epithelial regeneration in collagen-coated and uncoated patch grafts implanted into dog tracheas.

Authors:  K Hirai; Y Shimizu; T Hino
Journal:  J Exp Pathol (Oxford)       Date:  1990-02

2.  Epithelial injury and interstitial fibrosis in the proximal alveolar regions of rats chronically exposed to a simulated pattern of urban ambient ozone.

Authors:  L Y Chang; Y Huang; B L Stockstill; J A Graham; E C Grose; M G Menache; F J Miller; D L Costa; J D Crapo
Journal:  Toxicol Appl Pharmacol       Date:  1992-08       Impact factor: 4.219

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.